Evernest Financial Advisors LLC acquired a new position in shares of Abacus Life, Inc. (NASDAQ:ABL – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 67,300 shares of the company’s stock, valued at approximately $681,000. Evernest Financial Advisors LLC owned approximately 0.11% of Abacus Life at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of ABL. Allspring Global Investments Holdings LLC purchased a new position in shares of Abacus Life during the 2nd quarter valued at about $9,909,000. Principal Financial Group Inc. bought a new position in Abacus Life during the second quarter valued at approximately $8,105,000. Point72 Asset Management L.P. purchased a new position in shares of Abacus Life during the second quarter worth approximately $5,190,000. Mendon Capital Advisors Corp bought a new stake in shares of Abacus Life in the 2nd quarter worth approximately $4,974,000. Finally, Clearbridge Investments LLC purchased a new stake in shares of Abacus Life in the 2nd quarter valued at $4,342,000.
Abacus Life Trading Up 0.5 %
NASDAQ:ABL opened at $9.54 on Tuesday. The company has a 50-day moving average price of $10.07 and a 200-day moving average price of $10.36. The stock has a market cap of $609.84 million, a price-to-earnings ratio of 477.00 and a beta of 0.12. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.59. Abacus Life, Inc. has a 12 month low of $5.75 and a 12 month high of $13.25.
Analyst Ratings Changes
Several research firms have issued reports on ABL. TD Cowen began coverage on shares of Abacus Life in a research report on Wednesday, August 7th. They set a “buy” rating and a $14.00 price target for the company. B. Riley reaffirmed a “buy” rating and issued a $16.00 price target (up from $15.00) on shares of Abacus Life in a research note on Thursday, August 29th. B. Riley Financial reissued a “buy” rating and set a $16.00 price objective on shares of Abacus Life in a research note on Friday, August 30th. Finally, Piper Sandler started coverage on shares of Abacus Life in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $12.00 target price on the stock. Four investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $14.50.
Abacus Life Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Featured Articles
- Five stocks we like better than Abacus Life
- What Does Downgrade Mean in Investing?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- How to Choose Top Rated Stocks
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Learn Technical Analysis Skills to Master the Stock Market
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.